Concepedia
Statistics
Publications
14
Citations
640
H-Index
12
Active since
2008
Affiliations
Pfizer (United States)(Current)
Icahn School of Medicine at Mount Sinai
University of New Mexico
Vanderbilt University Medical Center
Tufts University
Jon D. Morrow is an author at Pfizer (United States) specializing in medicine, urogynecology, and urology.
Top concepts
UrologyMedicineUrogynecologyPharmacologyGynecologyWomen's HealthSurgeryAddictionSexual HealthPelvic Prolapse
Publications per year
2008–2022
Comparison of fesoterodine and tolterodine extended release for the treatment of overactive bladder: a head‐to‐head placebo‐controlled trial
Sender Herschorn, Steven Swift, Zhonghong Guan et al. · British Journal of Urology · 2009 · 159 citations
Randomized, Double-blind, Placebo-controlled Trial of Flexible-dose Fesoterodine in Subjects With Overactive Bladder
Roger R. Dmochowski, Kenneth M. Peters, Jon D. Morrow et al. · Urology · 2009 · 88 citations
Urological Research, Urology, Voiding Dysfunction +7
Efficacy of tolterodine on overactive bladder symptoms and sexual and emotional quality of life in sexually active women
Rebecca G. Rogers, Gloria Bachmann, Zhanna Jumadilova et al. · International Urogynecology Journal · 2008 · 81 citations
Urology, Voiding Dysfunction, Addiction +9
Effects of flexible-dose fesoterodine on overactive bladder symptoms and treatment satisfaction: an open-label study
Jean‐Jacques Wyndaele, Evan R. Goldfischer, Jon D. Morrow et al. · International Journal of Clinical Practice · 2009 · 79 citations · Full text
Efficacy and tolerability of fesoterodine in women with overactive bladder
Peter K. Sand, Jon D. Morrow, Tamara Bavendam et al. · International Urogynecology Journal · 2009 · 37 citations
Urological Research, Urology, Voiding Dysfunction +5
1–5 of 14